What is Veterinary Artificial Insemination Market?
The global veterinary artificial insemination market is expected to grow in the market due to an increasing burden of sexually transmitted diseases in animals. AI can reduce many of the risks involved with animal breeding and disease transmission, which is acting as a key factor in boosting market growth. Increasing productivity using AI technology is boosting market growth. Artificial insemination is a method of achieving pregnancy without sexual contact by injecting sperm or semen into the female cervix or uterine cavity. Cattle are raised using fresh, raw, or frozen straw of semen in this process. Artificial insemination is a technique for achieving animal pregnancy through in vivo fertilization. This process is often used to identify sperm defects.
The market study is being classified by Type (Equipment, Reagents and Kits and Other) and major geographies with country level break-up.
Merck Animal Health (United States), Bovine Elite (United States), Swine Genetics, LLC. (United States), PBS Animal Health (United States), Revival Animal Health (United States), ABS Global (United States), Jorgensen Labs (United States), Santa Cruz Biotechnology (United States) and IMV Technologies Group (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Alta Genetics (United States) and KRUUSE (Denmark).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Veterinary Artificial Insemination market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Veterinary Artificial Insemination market by Type, Application and Region.
On the basis of geography, the market of Veterinary Artificial Insemination has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Higher Prevalences of Transmitting Disease
- Increasing Adoption of Artificial Insemination Techniques
- Increasing Consumer Awareness about Benefits of Animal Protein
Market Trend
- Growing Demand for Products related to Fishery and Animal Husbandry
Restraints
Opportunities
- Growing Infectious Diseases in Animals
- Growth in Animal and Fishing Industry
Challenges
- Negative Impact of Artificial Insemination in Genetic Diversity
- Stringent Regulatory Policies
Market Leaders and some development strategies
High Cost of EquipmentIn May 2020, the Indian government announced fund around USD 2.13 billion for projects for the production of animal husbandry infrastructures.
In August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the United Kingdom., and In August 2019, Obstetrics of Madras Veterinary College and the Department of Veterinary, Gynecology started artificial insemination in cattle using sexed semen.
M A Hannan et al., published in the Journal of Veterinary Medical Science February 2019, Japan, embryo transfer in Japan by artificial insemination using frozen semen found to be useful in improving the productivity of Japanese domestic and special riding horses.
Key Target Audience
Veterinary Artificial Insemination Companies, Veterinary Clinics & Hospitals, Regulatory & Government Bodies, Research & Consulting Firms, Universities, Upstream & Downstream Vendors, End Users and Others